Sanofi Needs Switch Skills To Span Gap Between Rx And OTC Divisions
This article was originally published in The Tan Sheet
Executive Summary
Sanofi-Aventis will need to build an infrastructure geared to Rx-to-OTC switch in order to make a successful U.S. consumer business out of its planned acquisition of Chattem and become established as a switch player